Don't catch The Stupid! The Rob Carson Show is LIVE from Washington D.C. on NEWSMAX Radio! Watch Rob every weekday from Noon-3 PM ET on Rumble, YouTube, Facebook, X and Twitch. To talk to Rob, call 1-800-922-6680. E-mail Rob Carson at: RobCarsonShow@gmail.com Musical parodies provided by Jim Gossett (http://www.patreon.com/JimGossettComedy) Listen to Newsmax LIVE and see our entire podcast lineup at http://Newsmax.com/Listen Make the switch to NEWSMAX+ today, and watch anywhere, anytime! Get your 15-day free trial of NEWSMAX+ at http://NewsmaxPlus.com Looking for NEWSMAX caps, tees, mugs & more? Check out the Newsmax merchandise shop at : http://nws.mx/shop Follow NEWSMAX on Social Media: • Facebook: http://nws.mx/FB • X/Twitter:…
Getting a little tired of youth pastors teaching the Parable of the Talents and then asking you to go stack some chairs? Consider telling everyone you have the spiritual gift of encouragement.
Website: https://saltmustflow.com OTHER PLATFORMS: Rumble: https://rumble.com/c/SaltyCracker Locals: https://saltycracker.locals.com/ Twitter/X: https://x.com/SaltyCracker9 TikTok: https://www.tiktok.com/@salty_cracker_76 SUPPORT SALTY: Website: https://saltmustflow.com/support/ SubscribeStar: https://www.subscribestar.com/salty-cracker Cash App: https://cash.app/$saltmustflow Merchandise: https://saltmustflow.com/shop/ Mrs. Salty's Channel: https://www.youtube.com/channel/UChnZMOno3rthe1LHvcxufdw Music by: https://incompetech.com/ Crinoline Dreams In Your Arms --Disclaimer-- These are the opinions and ramblings of a foul-mouthed lunatic. They are for entertainment purposes only and are probably wrong. You listen at your own risk.
Weight-loss drugs like Ozempic could slow the progression of cancer in patients, according to recent studies.
Emerging research suggests that popular GLP-1 drugs, known for mainly weight loss and diabetes management, may also slow the progression of various types of cancer. PULSE POINTS WHAT HAPPENED: - DETAIL: According to a new series of studies, GLP-1 weight-loss drugs , such as Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro, can reduce cancer progression and mortality rates. One study of 10,000 patients, all with different types of cancer, done by the Cleveland Clinic Cancer Institute, observed a significant reduction in cancer progression among the patients. Lung cancer progression was halved in patients that took GLP-1 drugs while the progression of breast cancer decreased by 43 percent. The studies were observational, meaning…Open
